Acute hemodynamic effects and home therapy using a novel pulsed nasal nitric oxide delivery system in children and young adults with pulmonary hypertension - 28/08/11
, Donna Parker, RRT, Aimee Doran, CPNP a, Donna Parker, RRT b, John P. Kinsella, MD c, Steven H. Abman, MD bAbstract |
In 26 patients, we evaluated a novel pulsed nasal delivery system for nitric oxide (NO) that, in the short term, was as effective as continuous delivery for decreasing pulmonary artery pressure and pulmonary vascular resistance. In 2 patients, NO delivered in the home using this pulsing system was well tolerated for up to 2 years. The long-term safety, efficacy, and acceptability of NO delivered in the home remains to be studied.
Le texte complet de cet article est disponible en PDF.| This research was supported by grant number MO1 RR00069, General Clinical Research Centers Program, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland. Study gas and the inhaled nitric oxide pulsed delivery systems were provided by INO Therapeutics, Clinton, New Jersey. |
Vol 92 - N° 7
P. 886-890 - octobre 2003 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
